Evidence map›Paper›PMID 40205021›Full record

ArticleNPJ digital medicine2025

Development and validation of multimodal deep learning algorithms for detecting pulmonary hypertension.

Wei Zhao, Zhihua Huang, Xiaolin Diao, Zhan Yang, Zhihui Zhao, Yun Xia, Qing Zhao, Zhaohong Sun, Qunying Xi, Yanni Huo and 10 more

2 registry-linked trialsAbstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05566002 recruitingnot on this map

Artificial Intelligence-Assisted Evaluation of Pulmonary Hypertension

TypeobservationalSponsorChinese Pulmonary Vascular Disease Research GroupRan2022 to 2025Enrolled2,000ConditionsPulmonary Hypertension, Pulmonary Arterial HypertensionArmsRight heart catheterization
NCT07131241 recruitingnot on this map

Research on Dynamic Risk Prediction for Patients With Pulmonary Hypertension Based on Multimodal Data Fusion: A Prospective Observational Study

Typeobservational_patient_registrySponsorFirst Affiliated Hospital of Fujian Medical UniversityRan2025 to 2029Enrolled1,000ConditionsPulmonary Hypertension
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Observational
  4. Review
  5. Advancing the diagnosis of pulmonary arterial hypertension-a Brazilian perspective aligned with global standards.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wei Zhao *Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Zhihua Huang *Center for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Xiaolin DiaoDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Zhan YangDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Zhihui ZhaoCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Yun XiaDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Qing ZhaoCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Zhaohong SunDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Qunying XiCenter for Pulmonary Vascular Diseases, Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences, Shenzhen, 518057, Guangdong, China.
Yanni HuoDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Ou XuDepartment of Respiratory and Pulmonary Vascular Disease, Fuwai Yunnan Cardiovascular Hospital, Kunming, 650102, Yunnan, China.
Jiahui GengDepartment of Information Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Xin LiCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Anqi DuanCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Sicheng ZhangCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Luyang GaoCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Yijia WangCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Sicong LiCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China.
Qin LuoCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China. luoqin2009@163.com.
Zhihong LiuCenter for Respiratory and Pulmonary Vascular Diseases, Department of Cardiology, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037, Beijing, China. zhihongliufuwai@163.com.

Funding

Artificial Intelligence and Information Technology Application Fund of Fuwai Hospital, Chinese Academy of Medical Sciences 2022-AI01Beijing Municipal Natural Science Foundation 7202168Beijing Municipal Science and Technology Project Z181100001718200CAMS Innovation Fund for Medical Sciences 2020-I2M-C&T-B-055, 2021-I2M-C&T-B-032Capital's Funds for Health Improvement and Research (CFH) 2020-2-4033, 2020-4-4035"Double First-Class" Discipline Construction Fund of Peking Union Medical College and Chinese Academy of Medical Sciences 2019E-XK04-02National High Level Hospital Clinical Research Funding 2022-GSP-GG-35National High Level Hospital Clinical Research Funding 2022-GSP-PT-8
6 · The paper itself

Abstract

Transthoracic echocardiography (TTE), commonly used for initial screening of pulmonary hypertension (PH), often lacks sufficient accuracy. To address this gap, we developed and validated a multimodal fusion model for improved PH screening (MMF-PH). The study was registered in the ClinicalTrials.gov (NCT05566002, 09/30/2022). The MMF-PH underwent extensive training, validation, and testing, including comparisons with TTE and evaluations across various patient subgroups to assess robustness and reliability. We analyzed 2451 patients who underwent right heart catheterization, supplemented by a prospective dataset of 477 patients and an external dataset. The MMF-PH demonstrated robust performance across different datasets. The model outperformed TTE in terms of specificity and negative predictive value across all test datasets. An ablation study using the external test dataset confirmed the essential role of each module in the MMF-PH. The MMF-PH significantly advances PH detection, offering robust and reliable diagnostic accuracy across diverse patient populations and clinical settings.

Identifiers

PMID40205021
PMCPMC11982229

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.